Evidence map›Paper›PMID 41459520›Full record

ArticleFrontiers in immunology2025

Vinegar intake in patients undergoing immune checkpoint inhibitor therapy: food frequency questionnaire study.

Hirotsugu Ariizumi, Miyuki Shimazui, Chisato Ogawa, Mika Kaneki, Nanaho Saito, Emiko Mura, Risako Suzuki, Toshiaki Tsurui, Nana Iriguchi, Tomoyuki Ishiguro and 9 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Hirotsugu AriizumiDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Miyuki ShimazuiDivision of Nutrition, Showa Medical University Hospital, Tokyo, Japan.
Chisato OgawaDivision of Nutrition, Showa Medical University Hospital, Tokyo, Japan.
Mika KanekiDivision of Nutrition, Showa Medical University Hospital, Tokyo, Japan.
Nanaho SaitoDivision of Nutrition, Showa Medical University Hospital, Tokyo, Japan.
Emiko MuraDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Risako SuzukiDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Toshiaki TsuruiDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Nana IriguchiDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Tomoyuki IshiguroDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Yuya HirasawaDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Masahiro ShimokawaDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Ryotaro OhkumaDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Yutaro KubotaDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Atsushi HoriikeDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Satoshi WadaDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Kiyoshi YoshimuraDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.
Kouzou MurakamiDivision of Radiology, Department of Radiology, School of Medicine, Showa Medical University, Tokyo, Japan.
Takuya TsunodaDivision of Medical Oncology, Department of Medicine, School of Medicine, Showa Medical University, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The gut microbiome is increasingly recognized as a key modulator of immune checkpoint inhibitor (ICI) efficacy. Dietary factors, particularly fibers, may influence the microbiome and thus affect the ICI response. Although Western studies have suggested a link between high fiber intake and better outcomes, this relationship remains unclear in Japanese populations with different dietary habits. This study investigated dietary components associated with ICI response in Japanese patients with cancer. Methods: In total, 32 patients with carcinomas treated with ICIs were enrolled. Nutritional customs before ICI infusion were analyzed using a food frequency questionnaire. Results: Among the 331 dietary items, only vinegar (acetic acid) intake showed an independent association with the treatment response. Higher vinegar consumption correlated with significantly lower odds of nonresponse (P = 0.017). In contrast, total and fermentable dietary fiber intake showed no significant association with ICI efficacy or survival outcomes. Conclusions: Higher vinegar intake is associated with better ICI response in Japanese patients, whereas fiber has a limited effect. Thus, tailored dietary strategies are needed for optimal outcomes.

Indexed as

Acetic AcidImmune Checkpoint InhibitorsNeoplasmsAdultAgedAged, 80 and overDietary FiberFemaleGastrointestinal MicrobiomeHumansJapanMaleMiddle AgedSurveys and QuestionnairesTreatment OutcomeAcetic AcidDietary FiberImmune Checkpoint Inhibitorsacetic aciddietary fiberfood frequency questionnaireimmune checkpoint inhibitornutritionvinegar

Identifiers

PMID41459520
PMCPMC12738812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.